U.S. judge sentences Novelion's Aegerion in drug marketing case [Reuters (UK)]
NOVELION THERAPEUTICS INC COMMON SHARES (NVLN)
Last novelion therapeutics inc common shares earnings: 5/7 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.novelion.com
Company Research
Source: Reuters
U.S. judge sentences Novelion's Aegerion in drug marketing case | Reuters 3 Min Read BOSTON (Reuters) - A federal judge on Tuesday sentenced Aegerion Pharmaceuticals Inc for improperly marketing a cholesterol drug and ordered that some of the $40.1 million it agreed to pay to resolve a U.S. investigation go to the company’s victims. U.S. District Judge William Young in Boston had in November rejected an initial plea deal between the U.S. Justice Department and the Novelion Therapeutics Inc unit, saying it restricted his ability to impose a sentence. The judge sentenced Aegerion under a new deal that gave him discretion to determine how much it should pay. Young ordered it to pay $7.2 million, an amount it had from the start agreed to pay and that is part of the $40.1 million. But Young said he disagreed with treating that sum as a fine that would go to the government as the deal called for and said it would instead be made available to 91 patients who may have been harmed by Aegerion’
Show less
Read more
Impact Snapshot
Event Time:
NVLN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVLN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVLN alerts
High impacting NOVELION THERAPEUTICS INC COMMON SHARES news events
Weekly update
A roundup of the hottest topics